Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in c-KIT Mutated Advanced Melanoma
NCT00470470Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2007
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in melanoma, sponsored by National Cancer Institute. Started Apr 2007; status: completed.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00470470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470470.